Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.47M Sell
46,314
-339
-0.7% -$39.1K 0.03% 364
2026
Q1
$5.58M Buy
46,653
+7,400
+19% +$970K 0.04% 338
2025
Q4
$5.35M Buy
39,253
+2,988
+8% +$430K 0.04% 317
2025
Q3
$5.35M Buy
36,265
+205
+0.6% +$28.4K 0.04% 307
2025
Q2
$4.66M Buy
36,060
+1,276
+4% +$155K 0.04% 345
2025
Q1
$4.16M Buy
34,784
+820
+2% +$102K 0.04% 344
2024
Q4
$3.94M Sell
33,964
-694
-2% -$87.7K 0.04% 370
2024
Q3
$4.68M Buy
34,658
+688
+2% +$92K 0.05% 318
2024
Q2
$4.61M Sell
33,970
-4,006
-11% -$545K 0.05% 304
2024
Q1
$4.91M Buy
37,976
+1,769
+5% +$214K 0.05% 301
2023
Q4
$4.14M Sell
36,207
-547
-1% -$54.6K 0.05% 305
2023
Q3
$3.35M Buy
36,754
+938
+3% +$96.7K 0.05% 328
2023
Q2
$4.03M Buy
35,816
+7,392
+26% +$782K 0.05% 290
2023
Q1
$2.98M Buy
28,424
+808
+3% +$84.4K 0.04% 363
2022
Q4
$3.05M Buy
27,616
+3,420
+14% +$358K 0.05% 333
2022
Q3
$2.11M Buy
24,196
+2,532
+12% +$230K 0.04% 379
2022
Q2
$1.69M Sell
21,664
-4,557
-17% -$376K 0.03% 413
2022
Q1
$2.24M Buy
26,221
+688
+3% +$65.9K 0.04% 352
2021
Q4
$3.06M Buy
25,533
+4,333
+20% +$538K 0.05% 291
2021
Q3
$2.62M Sell
21,200
-882
-4% -$114K 0.05% 292
2021
Q2
$2.65M Buy
22,082
+14,428
+189% +$1.65M 0.05% 302
2021
Q1
$805K Sell
7,654
-121
-2% -$12.3K 0.02% 560
2020
Q4
$791K Buy
7,775
+520
+7% +$48.9K 0.02% 541
2020
Q3
$610K Sell
7,255
-36
-0.5% -$2.8K 0.02% 567
2020
Q2
$474K Buy
+7,291
New +$481K 0.01% 633

Other funds holding XYL

Xponance's XYL Position: Q2 2026 in Review

Xponance reduced its Xylem (XYL) stake by 0.73% in Q2 2026, selling an estimated $39.1K and leaving 46,314 shares worth $5.47M. The position accounts for 0.03% of the portfolio, ranked #364.

Xponance first reported a position in XYL in Q2 2020 and has held it in 25 quarters since. The position peaked at $5.58M in Q1 2026. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Xponance held 46,314 shares of Xylem worth $5.47M as of Q2 2026.
  • Xponance sold 339 Xylem shares in Q2 2026, an estimated $39.1K.
  • Xylem made up 0.03% of Xponance's portfolio in Q2 2026, its #364 holding.
  • Xponance first reported a position in Xylem in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Xylem position peaked at $5.58M in Q1 2026.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.